Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127303181 | 12730318 | 1 | I | 201608 | 20160822 | 20160909 | 20160909 | PER | US-ASTRAZENECA-2016SE90909 | ASTRAZENECA | 811.00 | MON | F | Y | 68.00000 | KG | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127303181 | 12730318 | 1 | PS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 22047 | 150 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
| 127303181 | 12730318 | 2 | C | LITHIUM. | LITHIUM | 1 | Oral | 0 | 300 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127303181 | 12730318 | Drug ineffective | |
| 127303181 | 12730318 | Insomnia | |
| 127303181 | 12730318 | Off label use | |
| 127303181 | 12730318 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127303181 | 12730318 | 1 | 201608 | 0 | ||
| 127303181 | 12730318 | 2 | 201607 | 0 |